Nyob, cov tshuaj tiv thaiv tsis zoo (piv txwv li, MMR, varicella, daj kub taub hau) thiab qee yam tshuaj tiv thaiv tsis ua haujlwm (xws li meningococcal polysaccharide) tau pom zoo los ntawm cov tuam txhab ua haujlwm los ntawm subcutaneous. txhaj tshuaj.
Puas yog cov tshuaj tiv thaiv kab mob hauv lub cev?
chloride (ib txwm saline, preservative-free) diluent raws li lub khw cov lus qhia. Ua raws li cov chaw tsim khoom cov lus qhia rau kev khaws cia / tuav cov tshuaj tiv thaiv sib xyaw. intramuscular (IM) txhaj.
Vim li cas cov tshuaj tiv thaiv kab mob tau txhaj tshuaj intramuscularly?
Zoo ib yam li lwm cov tshuaj tiv thaiv, cov tshuaj tiv thaiv COVID-19 yuav tsum tau txhaj tshuaj intramuscularly. Cov leeg muaj vascularity zoo, thiab yog li tso cov tshuaj txhaj kom ncav cuag cov kab mob hauv lub cev sai sai, hla kev ua ntej dhau ntawm cov metabolism.
Yog MMR subcutaneous lossis IM?
Kev tswj hwm MMR Vaccine
Cov koob tshuaj rau MMR thiab MMRV yog 0.5 mL. Ob leeg tshuaj tiv thaiv yog tswj hwm los ntawm txoj kev subcutaneous. Lub hnub nyoog tsawg kawg nkaus rau MMR thiab MMRV yog 12 lub hlis ntawm hnub nyoog. Lub hnub nyoog raug rau koob thib ob ntawm cov tshuaj tiv thaiv yog thaum muaj hnub nyoog 4 txog 6 xyoo.
Vim li cas MMR thiaj muab subcutaneous?
Feem ntau, cov tshuaj tiv thaiv uas muaj cov tshuaj tiv thaiv (ib qho khoom tiv thaiv uas txhim kho cov lus teb antigenic) yog tswj hwm IM rau zam kev khaus, induration, tawv nqaij, o, thiabgranuloma formationyog txhaj rau hauv cov ntaub so ntswg subcutaneous.
